BioNxt Solutions is advancing a diversified pipeline of innovative drug delivery technologies and therapeutic programs with the potential to transform patient care across oncology, neurology, autoimmune diseases, and longevity medicine.
Our development strategy focuses on high-impact areas where novel delivery platforms can unlock new value – whether by improving bioavailability, enhancing patient adherence, or enabling the use of therapies previously limited by toxicity. With programs spanning targeted chemotherapy, sublingual thin films, and transdermal patches, BioNxt is positioned to address significant unmet medical needs and major global markets.
Be in the know. Get our press releases and latest news first.
Hear about our latest research, products, exclusive partnerships & more.